Quick Answer
Tonix Pharmaceuticals Holding Corp. reported Total Revenue of $13.11 million for the year ending 2025.
- Tonix Pharmaceuticals Holding Corp. showed an increase of +29.8% in Total Revenue from 2024 to 2025.
- This data is from Tonix Pharmaceuticals Holding Corp.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2023: $3.99 million | Q1 2024: $2.48 million | Q2 2024: $2.21 million | Q3 2024: $2.82 million | Q1 2025: $2.43 million | Q2 2025: $2.00 million | Q3 2025: $3.29 million.
- Over the full 3 years of available data (2023 to 2025), Tonix Pharmaceuticals Holding Corp.'s Total Revenue has grown by 68.7%.
- Historical annual values: Fiscal year 2025: $13.11 million | Fiscal year 2024: $10.09 million | Fiscal year 2023: $7.77 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: